Maci-Dankovi A
(PubMed) Li Y, Huang T, Zheng Y, Muka T, Troup J, Hu FB
Toxics 11(4):384
Exenatide ER exenatide extended release, FAS full analysis set, MET metformin, N number of subjects randomised, OAD oral antidiabetic drug, RCT randomised controlled trial, SGLT2i sodiumglucose co-transporter 2 inhibitor, SU sulphonylurea, TZD thiazolidinedione a Only subjects receiving background MET and MET + SU were included in this analysis Semaglutide was added to existing stable background antidiabetic therapy (MET, TZD or both [SUSTAIN 2]
Gene therapy has recently taken a prominent part in the treatment of several ailments and has emerged as one of the hot issues in medicine
Administering the injection on the same day each week helps maintain consistent medication levels, which supports both effectiveness and tolerability